Clinical trial
A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible Dose Study of the Safety and Efficacy of EMSAM in Adolescents With Major Depression
NCT00531947 is registered in ClinicalTrials.gov with Somerset Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible Dose Study of the Safety and Efficacy of EMSAM in Adolescents With Major Depression
- Lead sponsor
- Somerset Pharmaceuticals
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- October 31, 2010
- Enrollment
- 308 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.